Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | FYN | P06241 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | MEP1B | Q16820 | 4/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 5/20 | 0.41 |
| ▸ | NAMPT | P43490 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | WDR5 | P61964 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13451131 | 0.81 | CYP1A2 (0.59) | CYP1A2LCKFYNCYP2C19MEP1B | |
| SCHEMBL12285932 | 0.77 | CYP1A2 (0.59) | CYP1A2LCKFYNALDH1A1MAPT | |
| SCHEMBL13380206 | 0.77 | CYP1A2 (0.54) | CYP1A2LCKFYNCYP2C19MEP1B | |
| SCHEMBL23471200 | 0.75 | PRSS1 (0.44) | NAMPT | |
| SCHEMBL12285528 | 0.75 | CA12 (0.45) | CYP2C19NAMPTALDH1A1 | |
| SCHEMBL13750577 | 0.74 | CYP1A2 (0.66) | CYP1A2LCKFYNCYP2C19MAPT | |
| SCHEMBL5041380 | 0.74 | CYP2C19 (0.49) | CYP2C19MEP1BAKR1C3ALDH1A1 | |
| SCHEMBL196841 | 0.74 | ALDH1A1 (0.42) | CYP2C19NAMPTALDH1A1 | |
| SCHEMBL197058 | 0.74 | FABP4 (0.49) | CYP2C19ALDH1A1 | |
| SCHEMBL9281374 | 0.73 | CYP2C19 (0.67) | CYP1A2CYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8883378-B2 | Colored curable composition, color filter and method of producing color filter, solid-state image sensor and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2014-11-11 | — | — | US | disclosed |
| US-8815478-B2 | Colored curable composition, resist liquid, ink for inkjet printing, color filter, method of producing color filter, solid-state image sensor, liquid crystal display, organic EL display, image display device and colorant compound | FUJIFILM CORPORATION (JP) | 2014-08-26 | — | — | US | disclosed |
| US-8637215-B2 | Colored curable composition, color filter and method of producing color filter, solid-state image sensor and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2014-01-28 | — | — | US | disclosed |
| US-20120264039-A1 | COLORED CURABLE COMPOSITION, RESIST LIQUID, INK FOR INKJET PRINTING, COLOR FILTER, METHOD OF PRODUCING COLOR FILTER, SOLID-STATE IMAGE SENSOR, LIQUID CRYSTAL DISPLAY, ORGANIC EL DISPLAY, IMAGE DISPLAY DEVICE AND COLORANT COMPOUND | FUJIFILM CORPORATION (JP) | 2012-10-18 | — | — | US | disclosed |
| US-20110217636-A1 | COLORED CURABLE COMPOSITION, COLOR FILTER AND METHOD OF PRODUCING COLOR FILTER, SOLID-STATE IMAGE SENSOR AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2011-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264039-A1 | COLORED CURABLE COMPOSITION, RESIST LIQUID, INK FOR INKJET PRINTING, COLOR FILTER, METHOD OF PRODUCING COLOR FILTER, SOLID-STATE IMAGE SENSOR, LIQUID CRYSTAL DISPLAY, ORGANIC EL DISPLAY, IMAGE DISPLAY DEVICE AND COLORANT COMPOUND | CDYL, RET, NLRP1 | CYP1A2 1954/4885LCK 1056/4885FYN 868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.